BEATW Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -164.2%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Heartbeam Inc. Warrant
Company profileHeartbeam Inc. Warrant (BEATW) offers a unique investment prospect linked to Heartbeam Inc., a pioneering healthcare technology firm dedicated to revolutionizing cardiac diagnostics via advanced artificial intelligence and digital health solutions. The company's innovative platform aims to increase the accuracy of myocardial infarction diagnoses, enabling timely and effective interventions that enhance patient care. As the demand for remote monitoring and telehealth services in cardiovascular health continues to rise, Heartbeam Inc. is strategically positioned to leverage this growth, making…
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- NONE
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer